A group of area hospitals and medical schools are creating the Philadelphia Coalition for a Cure, an initiative launched to speed the development of new ways to treat adult and pediatric brain tumors.
The coalition will include researchers from the division of neurosurgery and Center for Data Driven Discovery at The Children’s Hospital of Philadelphia and from the neurosurgical departments of the Perelman School of Medicine at the University of Pennsylvania, the Lewis Katz School of Medicine at Temple University, the Drexel University College of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, and Cooper Medical School of Rowan University.
The group also includes researchers from the Hyundai Cancer Institute at the Children’s Hospital of Orange County.
NantHealth, Inc. (NASDAQ: NH), a personalized health care company based in California, will supply participating researchers with access to its molecular profiling and diagnostics test, GPS Cancer, to help them develop better informed treatment strategies for patients with brain tumors. The coalition intends to share the resulting data with the worldwide research community.
“Brain tumors can occur at any age, and can be found in anyone,” said Dr. Jay Storm, chief of the Division of Neurosurgery at The Children’s Hospital of Philadelphia. “They are the leading cause of disease-related death in children and, this year alone, more than 20,000 adults will be newly diagnosed with brain tumors. Through the PC4C, CHOP, CHOC and the leading adult Philadelphia institutions are coming together to define a new clinical and research collaborative ecosystem that harnesses partnerships among leading academic centers, commercial partners and payers in order do what needs to be done on behalf of patients – identify therapies and accelerate discovery.
To read full article, click here.
Local
Breaking news and the stories that matter to your neighborhood.
For more business news, visit Philadelphia Business Journal.
